Bloomberg Businessweek

Transcription

Bloomberg Businessweek
April 1 — April 7, 2013 | businessweek.com
Samsung’s
Secret
How did the company that makes
everything win at smartphones?
Size—and the paranoia of
Chairman Lee Kun Hee
p58
Bloomberg
Businessweek
Contents
Opening Remarks
April 1 — April 7, 2013
Bloomberg Businessweek
Handling it
Hardworking
attachés p78
10
Bitcoin, the anarchist virtual currency, may just
be the global economy’s last safe haven
Bloomberg View What the EU must do in Cyprus;
gay marriage and the power of public opinion p12
Global
Economics
15
Companies &
Industries
23
Stumped at the gas pump
Despite a U.S. oil boom,
gas prices are still high—
partly because refiners are
boosting exports
The cost of cost-cutting
After trimming store staff,
Walmart is having trouble
stocking its shelves,
angering customers
Saudi land shortage The rise of the wearable
machines p24
China is lovely for L’Oréal
p25
p26
Is the Fed counting its
money right?
p17
p18
The U.S. shadow economy p19
Tom Keene’s EconoChat p19
Sunset for the Sun’s
Page 3 girls?
The week ahead p20
Briefs: Dell’s job insecurity p27
Politics &
Policy
29
Technology
35
The Pac-Man sequester
Phil Gramm’s efforts in
the 1980s to force better
budgeting may hold
lessons for today
All huffy at AOL
The company bet
$315 million on Arianna
Huffington’s distinctive
brand. Is it paying off?
A break on student loans
p30
China’s Internet originators p36
Obama’s green land grab
p30
Amazon’s pilot season
p37
Rand Paul woos Dad’s fans p31
DIY drones
p38
Chris Christie: Outearned
Innovator: Adieu, passwordsp39
by his wife and cool with it p32
Charlie Rose talks to Yahoo!
A dim policy on headlights p33
teen tycoon Nick D’Aloisio p40
Markets &
Finance
Health Care
42
51
A $25 billion beating
Brazilian billionaire Eike
Batista is having a very
bad year as stocks in his
companies slide
Prescription nannies
Companies are trying
an array of high-tech
solutions to get patients
to take their meds
What M&A boom? Obamacare scare: Double-digit
premium hikes?
p52
p43
The troubling return of CDOs
and their ilk p44
The crashing carbon marketp46
Bid&Ask: Picasso’s Le Rêvep47
Anti-Apple Samsung’s Galaxy models now outsell iPhones p58
Features
58
The Samsung Era
How the South Korean conglomerate became
the No. 1 smartphone maker—and its plans
to stay on top
p58
Screwed in Cyprus
With the €10 billion bailout deal, Europe’s leaders
say they’ve averted yet another crisis. Cypriots on
the street don’t see it that way
p66
Fall Guy or Crook?
A Chinese functionary is charged with embezzling
$14.5 million from the government. His story
shows how insidious corruption is among low-level
officials in China p70
Etc.
75
YouTube, the Star Maker
A new breed of musical outliers is parlaying fame
on the site into mainstream success
Fashion The brief on briefcases
p78
FAQ Will sponsors like Tiger Woods more? Is Lindsey Vonn aware of his past?
Everything you wanted to know about the new sports power couple
p80
Branding What Lululemon’s inadvertent transparency reveals
p81
A Chinese startup takes aim
at market leader Cochlear p53
Conspicuous Consumption The HBO series Game of Thrones beats any business
book at illuminating corporate power struggles
p82
Doubts about a promising
Parkinson’s treatment p54
Hard Choices Michael Graves on ending his partnership with Target and following
Ron Johnson to J.C. Penney
p84
cover: thomas traum; this page, from top: bobby doherty; michael nagle/bloomberg
5
Page
32
April 1 — April 7, 2013
Bloomberg Businessweek
A
●
Abe, Shinzo
19
ABI Research
24
Adcock Ingram Holdings
(AIP:SJ)
47
Aetna (AET)
52
Affiris
54
Agassi, Andre
80
Air France-KLM (AF:FP)
27
Akamai Technologies (AKAMI) 39
Alekstra
58
Aleph Objects
38
Alnylam Pharmaceuticals
(ALNY)
54
Alwazir, Mohammad
17
Alzumaie, Mohammed
17
Amazon.com (AMZN) 23, 37, 42
American Express (AXP)
75
American Residential
Properties
47
Amtrak
27
Anastasiades, Nicos
66
Anderson, Chris
38
Angelo Gordon
32
AOL(AOL)
35
47
Gramm, Phil
29
L’Oréal (LRLCY)
Chang Sea-Jin
58
Graves, Michael
84
Lululemon Athletica (LULU) 81
Parsons
17
Cheil Worldwide
58
Grupo BTG Pactual
Lyne, Susan 35
Paul, Rand
31
Christie, Chris
32
(BBTG11:BZ)
42
Macklemore
75
Paul, Ron
31
Christie, Mary Pat
32
Haier (1169:HK)
58
Mad Decent
75
PayPal (EBAY)
39
Hammer, Jan
75
Mahone, Austin
75
80
Malas, Stavros
66
Perakis-Valat, Alexis
25
Petrobras (PZE)
42
Phillips 66 (PSX)
15
Pimco
10
Poe, Ted
38
Popdust
75
Citigroup (C)
15, 19, 43, 44
25
Clark, Duncan
36
Hamm, Mia
Claybrook, Joan
33
Hangzhou Nurotron
ClimateCare
46
Biotechnology
53
Marc by Marc Jacobs
78
Cluttons
17
Hanrahan, Edward
46
Marks, Craig
75
CNBC (CMCSA)
52
Harada, Cesar
38
Mars
27
Coach (COH)
78
Harding, Nathan
24
Martin, George R.R.
82
Cochlear (COH:AU)
53
Harris (HRS)
39
Marvel Comics (DIS)
24
Marathon Petroleum (MPC) 15
Cohen, Steven
47
Maymann, Jimmy
35
ConAgra (CAG)
20
Heckman, James
18
May-Treanor, Misty
80
Conant, Douglas
82
H. Lundbeck
47
Mayweather, Floyd
80
HBO (TWX)
35, 82
Costco Wholesale (COST) 23
Home Depot (HD)
McConnell, Mitch
31
Cowell, Simon
75
Huang, Guangyu
70
McCoy Solar
30
CSM (CSM:NA) 47
Huawei (002502:CH)
58
McNamee, Roger
37
CVS Caremark (CVS)
51
Huffington, Arianna
35
MediSafe Project
51
Hyatt Hotels (H)
35
Mendham Capital Mgmt.
32
Cyprus Popular Bank
(CPB:CY)
66
●●●
23, 27
I J K
D E F
●●●
Mercedes-Benz (DAI)
33
Merkel, Angela
66
Miami Heat
75
Parker, Jim
82
PricewaterhouseCoopers 52
TNK-BP
47
Primus, Wendel
29
Toyota Motor (TM)
58
75
Treanor, Matt
80
Prince
Procter & Gamble (PG)
25, 58
Trudeau, Garry
37
38
Tumblr
26
Proteus Digital Health
51
Twitter
10, 26
Psy
75
Protei
●●●
80
Qiming Venture Partners
53
27, 43
Mintel Group
25
Rhodes, William
19
52
Mizrahi, Isaac
84
Rhone Capital
47
42
Moe, Jeff 38
Riff Raff
75
Argo Medical Technologies 24
De Juniac, Alexandre
27
Innovation Works
36
Moelis 43
Rihanna
75
Instagram
10
Mohan, Dominic
26
Roberts, Chris
53
36
Monsanto (MON)
20, 38
Dell, Michael
27
Intel Capital (INTC)
Rolex
80
Audi (VOW:GR)
33
Del Rey, Lana
75
Interscope Records (VIVHY) 75
Morgan Stanley (MS)
43
Rosneft (ROSN:LI)
47
Australian Broadcasting 53
Denters, Esmée
75
Ireland, Peter
18
Morse, Ed
15
Rousseff, Dilma
42
De Oliveira, Luma
42
IronFX
66
MPX Energia (MPXE3:BZ) 42
RWE (RWE:GR)
46
●
51
Van Eck Associates
42
47
Vassiliou, George
66
Safeway (SWY)
23
Verizon Communications (VZ) 43
Salazar, Ken
30
Verizon Wireless 27
Vickers Capital
36
Johnson, Ron
84
27, 84
N O
●●
Nakamoto, Satoshi
10
Bank of Cyprus (BOCY:CY) 66
Dooney & Bourke
78
JPMorgan Chase (JPM)32, 44, 47
Bank of Japan (8301:JP)
20
Driscoll, James
18
Karmali, Abyd
46
National Commercial Bank 17
Duke Energy (DUK)
30
Kennedy, Anthony
12
Nestlé (NESN:VX)
27
37
36
37
Bell Potter Securities
53
Ben Minkoff
78
Benton, Jesse
31
Berkshire Hathaway (BRK.A) 43
Bertolini, Mark
52
Best Buy (BBY)
27
Bezos, Jeff
37, 42
Bidvest Group (BVT:SJ)
47
Bieber, Justin
75
Billy Reid
78
Bitcoin
10
BlackBerry (BBRY)
58
Blackstone Group (BX) 27, 43, 47
Blair, Tony
46
BMW (BMW:GR)
33
Boeing (BA)
38
Bono
32
BP (BP)
47
Brown, Sherrod
44
Buffett, Warren
43
Burker King (BKW)
10
Bush, George W. 30
BuzzFeed
10
C
●
Campbell Soup (CPB)
82
EBay (EBAY)
10
Kesanupalli, Ramesh
39
Netflix (NFLX)
EBX Group
42
Kimbra
75
NeuroPhage Pharmaceuticals 54
Eclat Textile (1476:TT)
81
King Abdullah
17
Newman, Mark
58
EClinicalWorks
51
King, David
46
News Corp. (NWS)
26
Economic Outlook Group
19
Klesse, Bill
15
Next Big Sound
75
EDF Renewable 30
Kohl’s (KSS)
23
Nokia (NOK)
58
Ekso Bionics 24
Kuroda, Haruhiko
19
Nok Nok Labs
39
Elan (ELN)
54
Kuzcma, Ed
42
Nordegren, Elin
80
Emirates
27
Esteves, André
42
Euromonitor International
25
ExxonMobil (XOM)
46
Facebook (FB) 10, 26, 66, 80, 81
25
Face Shop (973:HK)
Northrop Grumman (NOC) 38
●●
NXP Semiconductors (NXPI) 39
L M
Obama, Barack
Ginsburg, Ruth Bader
12
24
Goldman Sachs (GS)
43
32
Google China (GOOG)
36
Carlsberg (CARLA:DC)
46
Google (GOOG)
Carr, Bill
37
10, 35, 58
Gosar, Paul
38
Cazenove Capital Holdings 47
Gotye
75
CBRE Group (CBG)
Graf, Steffi
80
47
Short, Clare
26
Silver Lake Management
27
Simon, Bill
23
Sina (SINA)
36
Skype (MSFT)
75
Spinetta, Jean-Cyril
27
Springsteen, Bruce
25
Goffer, Amit
Shire (SHPG)
70
L’Occitane (COC:GR)
17
36
Ouyang, Changqing
43
Ghosheh, Adnan
36
75
Sequoia Capital
82
70
80
44
47
Seacrest, Ryan
Southwest Airlines (LUV)
Li Huabo
Genworth Financial
Warren, Elizabeth
WeChat Schroders (SDR:LN)
47
Life Technologies (LIFE)
58
58
Otsuka Holdings 54
33
Walt Disney (DIS)
58
Fox, Michael J.
38
15
58
40
General Motors (GM)
23
Schork, Stephen
Sony (SNE)
Li Ka-shing
38
Wal-Mart Stores (WMT)
42
32
General Electric (GE)
Walgreen (WAG)
15
OSX Brasil (OSXB3:BZ)
Fleet Securities
General Dynamics (GD)
47
Schork Group 42
53
General Atomics
23
●
P
44
SARcode Bioscience 39
Li Fangping
58
80
(OGXP3:BZ)
78
80
43
Vonn, Lindsey
Onset Ventures
44
Gartner (IT)
Vodafone Group (VOD)
58
Sanford C. Bernstein (AB) 58
58
Fisher, Richard
51
Samsung Life Insurance
Lee, Keon-Hyok
39, 58
Vitality
Vitter, David
58
Filson + Apolis
Garciaparra, Nomar
58
36
Lenovo (0992:HK)
●●
OGX Petróleo e Gás
(005930:KS)
Samsung Heavy Industries 58
Lee, DJ
Lee, Kun-Hee
G H
30, 46
Samsung Electronics
Lee, Kai-Fu 18
Fayyad, Salam
Cantor Fitzgerald 17
78
39
SAC Capital Advisors
82
Begley Jr., Ed
Valextra
Validity Sensors
RxAnte
Dinklage, Peter
BDA China
42
75
75
42
15
Vale (VALE)
26
Jepsen, Carly Rae
42
Valero Energy (VLO)
Murdoch, Rupert
J.C. Penney (JCP)
Batista, Thor
36
MTV (VIA)
12
Batista, Eike
75
Uucun
75
Dijsselbloem, Jeroen
18
75
Usher
24
Deutsche Lufthansa (LHA:GR) 27
44
Upton, Kate
Jasinski, Larry
78
Barnett, William
75
Island Def Jam
43
75
Barofsky, Neil
(VIVHY)
Universal Republic Records 75
Deutsche Bank (DB)
Bally
43, 46
Universal Music Group
DeStefano-Orebaugh, Lisa 27
Baauer
Bank of America (BAC)
●●●
U V W
Q R S
ING (ING)
B
46
25
Ignagni, Karen
27, 51
38
Tillerson, Rex
Tmall
39
AT&T (T)
3D Robotics
T-Mobile USA (DTE:GR) 27, 80
37
44
27, 43, 47
Tencent Holdings (TCEHY) 36
Price, Roy
Daniel Tarullo
Dell (DELL)
38
Prana Biotechnology (PRAN) 54
DCM
35
39
Teal Group
75
Mickelson, Phil
Icahn, Carl
23, 84
Tata 35
39, 58
40
Target (TGT)
Time Warner (TWX)
IBM (IBM)
D’Aloisio, Nick
T
●
Timberlake, Justin
Apple (AAPL)10, 27, 40, 58, 84
Armstrong, Tim
6
CBS (CBS)
Weibo
36
Woods, Tiger
80
Wynn, Steve
47
●●●
x yz
Xi Jinping
19, 36
Xu Chaojun
36
Xu Detang
70
32
Yahoo! (YHOO)
40
Stewart, Martha
82
Youku (YOKU)
Strategy Analytics
58
YouTube (GOOG)
36
36, 75
PaPa 36
Strickland, David
33
Zeng, Fan-Gang
53
Lockheed Martin (LMT) 24, 38
Paris Presents
19
Summly
40
Zhang Zhendong
36
Lofgren, Zoe
Parker Hannifin (PH)
24
Syson, Kristian
17
ZTE (000063:CH)
58
38
How to Contact Bloomberg Businessweek
Editorial 212-617-6231 Ad Sales 212-617-2900 Subscriptions 800-635-1200
Address 731 Lexington Ave., New York, NY 10022
E-mail bwreader@bloomberg.net Fax 212-617-9065
Subscription Service PO Box 37528, Boone, IA 50037-0528
E-mail bwkcustserv@cdsfulfillment.com
Reprints/Permissions 800-290-5460 x100 or businessweekreprints@theygsgroup.com
Letters to the Editor can be sent by e-mail, fax, or regular mail. They should include address, phone
number(s), and e-mail address if available. Connections with the subject of the letter should be disclosed,
and we reserve the right to edit for sense, style, and space.
from left: timothy a. clary/afp/getty images; charlie neibergall/ap photo; hassan ammar/ap photo
Index
Page
17
Page
29
A Chinese Hearing Implant Takes Aim at Cochlear - Businessweek
9 of 14
http://www.businessweek.com/articles/2013-03-28/a-chinese-hearing-im...
Will Hillary Clinton Run for President in 2016?
Iron Man Meets HULC: Suit with Super-Human Strength
Myanmar Offers Rich Potential: Maersk
Michigan's Right-To-Work Law: Bottom Line (3/28)
Illustration by Joe Magee
Devices
A Chinese Hearing Implant Takes Aim at Cochlear
By Bruce Einhorn and Natasha Khan on March 28, 2013
Tweet
Facebook
LinkedIn
Google Plus
2 Comments
Email
3/30/2013 6:14 PM
A Chinese Hearing Implant Takes Aim at Cochlear - Businessweek
10 of 14
http://www.businessweek.com/articles/2013-03-28/a-chinese-hearing-im...
Print
Special Report
Focus On Health Care, March 2013
'Take Your Pills' Reminders From Apps and Gadgets
Pharma Pipelines, by the Numbers
Obamacare Scare: Double-Digit Premium Hikes?
A Setback on the Road to a Parkinson's Cure
Companies Mentioned
COH
Cochlear Ltd
$68.05 AUD
-0.35
-0.51%
Market data is delayed at least 15 minutes.
Company Lookup
After suddenly going deaf at age 30, Ke Liu, a civil servant in China’s eastern Jiangxi province, didn’t have many options. A cochlear implant might’ve restored his
hearing, but the imported device cost tens of thousands of dollars. In 2010, Ke learned about a clinical trial for an implant made by a Chinese company, Hangzhou
Nurotron Biotechnology. That year he had one surgically implanted and has since recovered nearly all of his hearing. “I have my old life back,” says the 38-year-old.
Unlike hearing aides, which simply amplify sound, cochlear implants translate soundwaves into signals sent directly to the brain. Nurotron has received approval from
China’s health regulators to sell its implant on the mainland. At 98,000 yuan ($16,000), the price of its devices is less than half that of imported implants, says Nisa
Leung, a board member who is a partner at Qiming Ventures Partners, a venture capital firm and an investor in Nurotron.
That price gap threatens companies that dominate the estimated $1 billion market for cochlear implants. The leader is Australia’s Cochlear (COH), which sold more than
$600 million of the devices in its 2012 fiscal year ended June. Cochlear has enjoyed “a virtual monopoly,” says Stuart Roberts, an analyst with Bell Potter Securities in
Sydney. He notes the price of cochlear implants has barely budged over the years, while other sophisticated electronics—such as computer chips—have gotten less
expensive even as quality has improved.
That’s what motivated Fan-Gang Zeng to try to come up with a cheaper alternative. The Chinese native, who has a Ph.D. in hearing science from Syracuse University, is
director of the Center for Hearing Research at the University of California at Irvine. Zeng, who launched Nurotron in 2005, says finding researchers to work on his
project was not a problem. “Cochlear made a lot of enemies along the way,” Zeng says of the company’s pricing. “So when we asked for help, we got help.” Cochlear
declined to be interviewed for this story.
Nurotron also got plenty of assistance in China, where there are 28 million deaf people and 30,000 babies born without hearing each year. The government, the Chinese
Academy of Sciences, and state-backed hospitals contributed about 75 percent of the startup’s initial funding of 30 million yuan (about $3.7 million at the time), Zeng
says. Mainland authorities were also willing to fast-track the approval process, which usually takes three to five years. After wrapping up clinical trials in 2010, Nurotron
secured permission in less than a year to have its cochlear implants used in patients aged six and older.
If low-cost options such as Nurotron’s make cochlear implants as popular in China as they are in the U.S., “we are talking about 100,000 devices a year,” says Zeng, who
now heads development at Nurotron. The company is focused on basics, such as building a sales team and training Chinese doctors to perform the operation. It’s also
contemplating expanding into Latin America, according to Li Fangping, a former real estate developer who’s now the company’s president. Zeng says Nurotron will
“eventually” consider applying for approval in the U.S. and hopes the U.S. Food and Drug Administration will accept data from the Chinese trials.
In India, government-backed researchers are starting clinical trials of a locally developed device, says Dr. J.M. Hans, chairman of the ENT and cochlear implant
department at the Rockland Group of Hospitals in the New Delhi area. It will take “another two years before trials are done and we are sure the thing works,” says Hans.
If it does, a made-in-India implant could cost as little as $2,500.
Cochlear’s Sydney-listed shares are down 13.5 percent this year, compared with a 7.4 percent increase for Australia’s benchmark index, amid sluggish sales in the U.S.,
Europe, and developed Asia. “China offers a huge opportunity,” Chief Executive Officer Chris Roberts told the Australian Broadcasting Corp. on Feb. 10. But only if
Cochlear has a solution for the local competition.
Nurotron’s Li says his company’s low-cost manufacturing base gives it an edge over its Australian rival. “The raw materials for our products are the same,” he says. “The
difference is, if it costs us 3,000 yuan per worker, it might cost them $3,000 per worker.”
The bottom line: A Chinese startup threatens to upend the $1 billion market for cochlear implants with a low-cost alternative.
Einhorn is Asia regional editor in Bloomberg Businessweek's Hong Kong bureau. Khan is a reporter for Bloomberg News in Hong Kong.
Tweet
3/30/2013 6:14 PM
A Chinese Hearing Implant Takes Aim at Cochlear - Businessweek
11 of 14
http://www.businessweek.com/articles/2013-03-28/a-chinese-hearing-im...
Facebook
LinkedIn
Google Plus
2 Comments
Email
Print
by Taboola
by Taboola
2 comments
Best
0
Community
O_Pinion
•
Share
2 days ago
Interesting to note that Chinese authorities were able to grant this company an approval in 12 months when it would usually takes 3-5 years. What does that tell
you about how local companies are "favored" by the Chinese government. While it would be a step too far to say this is evidence of corruption it does indicate that the
Chinese regulatory regime has a long way to go before it can be classed as robust and independent.
0
•
Reply
•
Share ›
James LaCroix
O_Pinion • 3 hours ago
Any other government would do the same.
0
•
Reply
•
Share ›
What's this?
ALSO ON BUSINESSWEEK.COM
Expensify Brings Bitcoin to Main Street
Coming to a City Near You: Chinese Business Incubators
5 comments • 2 days ago
5 comments • 23 days ago
BitSpend — You can also spend your Bitcoins anywhere you want, using
https://bitspend.net. So while Bitcoins may not be accepted at all retailers yet, Bitspend
makes it possible for you to buy ANYTHING and pay with Bitcoins. (yeah, it's a shameless
Taishanese — We need more cross border investments from China. One thing we need to
keep in mind, is that as China increases her investments in the US, she still has a ways to
go to catch up with Japan's cumulative investments in the US of over $300 billion. And a
Apple, Volkswagen Face the Wrath of Chinese Media
3 comments • 3 days ago
yi xiong — china just did what it should do, protect domestic companies, and you are
brainless to believe all the American media are unbiased.
Feed
Most Popular
Read
Shared
Discussed
3/30/2013 6:14 PM